Changes in oncological surgical volume and postoperative survival during the COVID-19 pandemic: a retrospective multicenter study in a regional German hospital network - Report - MDSpire
Conexiant’s news site is now MDSpire News. Learn more
Advertisement
Impact of the COVID-19 Pandemic on Surgical Volume and Postoperative Survival in Oncology: A Retrospective Study Across a Regional German Hospital Network
Impact of the COVID-19 Pandemic on Surgical Volume and Postoperative Survival in Oncology
Overview
This study evaluates the impact of the COVID-19 pandemic on surgical volume, tumor stage distribution, and postoperative survival in oncology across a regional German hospital network. Findings indicate a decrease in surgical volume and an increase in advanced tumor stages during the pandemic.
Background
The COVID-19 pandemic significantly disrupted healthcare systems worldwide, leading to the postponement of elective surgeries and a decrease in oncological procedures. This study provides insights into how surgical volume and patient outcomes were affected during different pandemic phases.
Data Highlights
Period
Number of Operations
UICC Stage IV Proportion
Hazard Ratio (HR)
Pre-pandemic
952
23.9%
0.78
Pandemic
940
26.8%
Post-pandemic
979
24.2%
Key Findings
The minimum surgical volume recorded was 20 operations in April 2020 and December 2021.
UICC stage IV disease was more prevalent during the pandemic (26.8%) compared to pre-pandemic (23.9%) and post-pandemic (24.2%) periods.
Kaplan–Meier analysis suggested a trend towards reduced postoperative overall survival during the pandemic (log-rank p = 0.066).
After adjusting for age, sex, tumor stage, and resection site, the hazard of death was significantly lower in the pre-pandemic cohort (HR 0.78, p = 0.005).
Overall, 2871 oncological surgical procedures were evaluated across the three periods.
Clinical Implications
Understanding the impact of delayed surgeries on tumor stages and survival can inform future strategies for managing cancer care during similar disruptions.
Conclusion
The study highlights significant changes in surgical volume and patient outcomes during the COVID-19 pandemic.
The goal of this clinical trial is to learn if Adaptive Radiation Therapy (ART) is safe and effective in treating patients with locally advanced pancreatic cancer.